ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

50 hedge funds and large institutions have $4.23M invested in Zynerba Pharmaceuticals, Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 14 closing their positions.

Holders
50
Holders Change
-12
Holders Change %
-19.35%
% of All Funds
0.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
13
Reduced
16
Closed
14
Calls
$37K
Puts
$5K
Net Calls
+$32K
Net Calls Change
-$24K
Name Holding Trade Value Shares
Change
Shares
Change %
GSC
51
Ground Swell Capital
South Carolina
-$19K -25,445 Closed
Verition Fund Management
52
Verition Fund Management
Connecticut
-$15K -20,078 Closed
T. Rowe Price Associates
53
T. Rowe Price Associates
Maryland
-$14K -18,200 Closed
PWA
54
PCG Wealth Advisors
Kansas
-$12K -15,200 Closed
VF
55
Virtu Financial
New York
-$11K -14,812 Closed
LPL Financial
56
LPL Financial
California
-$9K -12,563 Closed
Goldman Sachs
57
Goldman Sachs
New York
-$8K -11,344 Closed
AAP
58
Arax Advisory Partners
Colorado
-$5K -6,648 Closed
Toronto Dominion Bank
59
Toronto Dominion Bank
Ontario, Canada
-$1K -1,056 Closed